in

U.S. Senate negotiators reach deal on $10 billion for COVID aid

The compromise, if passed, would be less than half of the $22.5 billion initially sought by U.S. President Joe Biden to combat COVID, prepare for future variants and shore up the nation’s pandemic infrastructure.

White House Press Secretary Jen Psaki in a statement urged Congress to move “promptly.”

Biden has said more funding is needed as the world continues to fight COVID in the pandemic’s third year. While U.S. officials have said they do not expect a surge from the latest BA.2 Omicron variant, they have pointed to the need to continue to make vaccines available at no cost and to boost surveillance and testing.

U.S. regulators last week approved a second booster shot for older and immunocompromised Americans, but administration officials have said without more funding from Congress money will run out for the free shots.

“The consequences of inaction are severe,” Biden warned lawmakers at a White House event last week.

Lawmakers had been weighing a $15 billion measure that included $5 billion in international aid. Health experts have said without full global immunization efforts the virus can continue to mutate, increasing the risk of infection and vaccine evasion.

Members of Congress negotiating the package, however, could not agree on how to pay for the global response.

One of the negotiators, Republican Senator Mitt Romney, said he was open to funding global efforts in a separate, “fiscally-responsible solution” in coming weeks.

A Senate vote on the $10 billion measure could come as soon as this week. Approval would send it to the House of Representatives.


Source: Economy - investing.com

More contagious omicron BA.2 on track to displace other variants in U.S. in next two weeks

Senators reach $10 billion Covid funding deal for therapeutics, vaccines and testing